首页 | 本学科首页   官方微博 | 高级检索  
     

丹参预防ERCP术后高淀粉酶血症及胰腺炎的临床疗效观察
引用本文:韦良宏,陈海东,宁琳,韦良鹏,苏东兴. 丹参预防ERCP术后高淀粉酶血症及胰腺炎的临床疗效观察[J]. 微创医学, 2014, 0(3): 284-286
作者姓名:韦良宏  陈海东  宁琳  韦良鹏  苏东兴
作者单位:广西钦州市第一人民医院消化二科,钦州市535000
基金项目:广西卫生厅科研项目(合同号:Z2013749)
摘    要:目的探讨丹参预防内镜逆行胰胆管造影(ERCP)术后高淀粉酶血症及胰腺炎的疗效。方法选择胆石症行ERCP术患者31例,ERCP术后常规给予常规鼻胆引流、抗感染、抑制胰酶分泌等治疗;于ERCP术前及术后1 d,予丹参注射液250 mL,每日2次静点。分别于术前、术后3 h、24 h抽血,检测血淀粉酶、脂肪酶水平、24 h C反应蛋白(CRP)。结果发生高淀粉酶血症10例,无胰腺炎发生。结论丹参对ERCP术后预防高淀粉酶及胰腺炎有一定的临床价值。

关 键 词:丹参  内镜逆行胰胆管造影  胰腺炎  高淀粉酶血症

Clinical investigation of Tanshinone in preventing hyperamylasemia and pancreatitis following endoscopic retrograde cholangiopancreatography
WEI Lianghong,CHEN Haidong,LIN Lin,WEI Liangpeng,SU Dongxing. Clinical investigation of Tanshinone in preventing hyperamylasemia and pancreatitis following endoscopic retrograde cholangiopancreatography[J]. Minimally Invasive Medicine Journal, 2014, 0(3): 284-286
Authors:WEI Lianghong  CHEN Haidong  LIN Lin  WEI Liangpeng  SU Dongxing
Affiliation:(The Second Department of Gastroenterology, the First People' s Hospital of Qinzhou City, Qinzhou 535000, Guangxi, P. R. China)
Abstract:Objective To observe the clinical effects of Tanshinone in preventing hyperamylasemia and pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP). Methods Thirty-one cholelithiasis patients routinely received, antibiotics, and pancreatin depressing after ERCP, as well as intravenous injection of Tanshinone( a dose of 250mi, twice a day right before ERCP and 1 day after ERCP). The level of serum amylase and lipase at right before ERCP, 3 h after, and 24h after ERCP, and CRP at 24h after ERCP were measured. Results Ten cases of hyperamylasemia happened, but no pancreatitis occurred. Conclusion Tanshinone has certain clinical value in preventing hyperamylasemia and pancreatitis following ERCP.
Keywords:Tanshinone  Endoscopic retrograde cholangiopancreatography  Pancreatitis  Hyperamylasemia
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号